Recent Reports:

• Eupraxia Phase 2b RESOLVE Trial Update: A Promising… Eupraxia Pharmaceuticals Inc. (EPRX) – Investment Snapshot Stock Price: US$5.40…
• Eupraxia’s EoE Breakthrough: Cohort 6 Shines Bright,… Eupraxia Pharmaceuticals Inc. (EPRX - Nasdaq and TSX) is a…
• Eupraxia – The Precision Delivery Platform Eupraxia Pharmaceuticals Inc. (EPRX) is a clinical-stage biotechnology company headquartered…
• Eupraxia’s EP-104GI Demonstrates Unprecedented… Eupraxia Pharmaceuticals Inc. (EPRX) - Investment Snapshot Date: September 02,…
• Advancing EoE Treatment Amid Biologic Setbacks: CLDX… Eupraxia Pharmaceuticals Inc. (EPRX) – Investment Snapshot Date: August 20,…